1. Home
  2. HWKN vs LGND Comparison

HWKN vs LGND Comparison

Compare HWKN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HWKN
  • LGND
  • Stock Information
  • Founded
  • HWKN 1938
  • LGND 1987
  • Country
  • HWKN United States
  • LGND United States
  • Employees
  • HWKN N/A
  • LGND 68
  • Industry
  • HWKN Specialty Chemicals
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • HWKN Consumer Discretionary
  • LGND Health Care
  • Exchange
  • HWKN Nasdaq
  • LGND Nasdaq
  • Market Cap
  • HWKN 3.5B
  • LGND 3.2B
  • IPO Year
  • HWKN N/A
  • LGND 1992
  • Fundamental
  • Price
  • HWKN $167.14
  • LGND $166.75
  • Analyst Decision
  • HWKN Buy
  • LGND Strong Buy
  • Analyst Count
  • HWKN 2
  • LGND 8
  • Target Price
  • HWKN $200.00
  • LGND $144.71
  • AVG Volume (30 Days)
  • HWKN 158.7K
  • LGND 139.7K
  • Earning Date
  • HWKN 10-29-2025
  • LGND 08-05-2025
  • Dividend Yield
  • HWKN 0.43%
  • LGND N/A
  • EPS Growth
  • HWKN 5.20
  • LGND N/A
  • EPS
  • HWKN 4.05
  • LGND N/A
  • Revenue
  • HWKN $1,011,824,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • HWKN $15.35
  • LGND $18.41
  • Revenue Next Year
  • HWKN $6.76
  • LGND $18.87
  • P/E Ratio
  • HWKN $41.32
  • LGND N/A
  • Revenue Growth
  • HWKN 9.51
  • LGND 53.40
  • 52 Week Low
  • HWKN $98.30
  • LGND $81.74
  • 52 Week High
  • HWKN $185.50
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • HWKN 48.96
  • LGND 75.21
  • Support Level
  • HWKN $163.22
  • LGND $158.40
  • Resistance Level
  • HWKN $173.80
  • LGND $161.89
  • Average True Range (ATR)
  • HWKN 4.46
  • LGND 3.32
  • MACD
  • HWKN -1.25
  • LGND 0.09
  • Stochastic Oscillator
  • HWKN 30.41
  • LGND 86.29

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: